Relement CTO Stefano Iannacone said, “Carrying out process optimization studies are important milestones for bio MPA commercialization. In the chemical world, innovative start-ups like Relement often encounter financial hurdles to scale-up their production process. Typically, a pilot facility is needed which requires significant capital investment and resources. To minimize risks and to speed up our technology scale-up, we have therefore scouted the chemical innovation landscape and found that several large chemical companies have R&D assets and know-how open for external selected collaborations. We believe that Solvay R&IC Lyon is a great partner to assist Relement in our journey towards commercial scale.”

Invest-NL Senior Business Developer Guus Dubbink added, “We helped Relement to develop an innovative new business model helping to overcome the first financial hurdles, based on outsourcing the demonstration step. Invest-NL supports Relement in its mission to commercialize and scale-up production. Furthermore, the learnings will be shared to the bio-based chemistry community, thereby helping similar Dutch start-ups.”